SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012140
Filing Date
2018-05-09
Accepted
2018-05-09 09:43:10
Documents
66
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-10q_20180331.htm 10-Q 1925095
2 EX-31.1 mcrb-ex311_7.htm EX-31.1 11501
3 EX-31.2 mcrb-ex312_8.htm EX-31.2 11478
4 EX-32.1 mcrb-ex321_6.htm EX-32.1 7635
5 EX-32.2 mcrb-ex322_9.htm EX-32.2 7674
  Complete submission text file 0001564590-18-012140.txt   6885956

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mcrb-20180331.xml EX-101.INS 1687635
7 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20180331.xsd EX-101.SCH 40087
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20180331_cal.xml EX-101.CAL 38061
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20180331_def.xml EX-101.DEF 130512
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20180331_lab.xml EX-101.LAB 295072
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20180331_pre.xml EX-101.PRE 259176
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 18816992
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences